Cerus Corporation
CERS
#7684
Rank
C$0.64 B
Marketcap
C$3.19
Share price
-6.56%
Change (1 day)
54.69%
Change (1 year)

Earnings for Cerus Corporation (CERS)

Earnings in 2026 (TTM): C$1.67 Million

According to Cerus Corporation's latest financial reports the company's current earnings are C$0.22 Billion. In 2025 the company made an earning of -C$9.7 Million, an increase over its 2024 earnings that were of -C$16.6 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus Corporation from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$1.67 M-117.27%
2025 -C$9.7 Million-41.58%
2024 -C$16.6 Million-58.95%
2023 -C$40.44 Million-20.74%
2022 -C$51.01 Million-25.7%
2021 -C$68.66 Million-11.99%
2020 -C$78.01 Million-14%
2019 -C$90.71 Million21.73%
2018 -C$74.52 Million-0.65%
2017 -C$75.01 Million-10.96%
2016 -C$84.24 Million4.24%
2015 -C$80.82 Million50.99%
2014 -C$53.53 Million-10.08%
2013 -C$59.53 Million184.13%
2012 -C$20.95 Million-7.91%
2011 -C$22.75 Million
2009 -C$32.13 Million-24.69%
2008 -C$42.66 Million-25.2%
2007 -C$57.04 Million330.54%
2006 -C$13.25 Million1.49%
2005 -C$13.06 Million-61.02%
2004 -C$33.49 Million
2002 -C$82.83 Million10.02%
2001 -C$75.29 Million34.25%
2000 -C$56.08 Million61.02%
1999 -C$34.83 Million-18.81%
1998 -C$42.9 Million93.08%
1997 -C$22.22 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
C$5.22 B 305,369.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
C$18 M 951.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
C$0.22 B 12,987.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-C$23.09 Million-1,448.57%๐Ÿ‡บ๐Ÿ‡ธ USA